Filing Details
- Accession Number:
- 0000905729-15-000095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-03 15:23:27
- Reporting Period:
- 2015-02-27
- Filing Date:
- 2015-03-03
- Accepted Time:
- 2015-03-03 15:23:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
19612 | Chemical Financial Corp | CHFC | State Commercial Banks (6022) | 382022454 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1213674 | A Lori Gwizdala | 235 E. Main Street Midland MI 48640 | Evp, Cfo & Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-02-27 | 4,477 | $0.00 | 41,472 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-27 | 1,415 | $30.18 | 40,057 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-02-27 | 1,166 | $30.38 | 38,891 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2015-02-27 | 4,070 | $0.00 | 4,070 | $0.00 |
Common Stock | Stock Options | Acquisiton | 2015-02-27 | 7,674 | $0.00 | 7,674 | $30.18 |
Common Stock | Restricted Stock Units | Acquisiton | 2015-02-27 | 4,749 | $0.00 | 4,749 | $0.00 |
Common Stock | Restricted Stock Units | Acquisiton | 2015-02-27 | 712 | $0.00 | 712 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
7,674 | 2025-02-28 | No | 4 | A | Direct | |
4,749 | No | 4 | A | Direct | ||
712 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 650 | Indirect | By husband in trust |
Footnotes
- Restricted stock units converted into shares of common stock upon the attainment by the Company of certain financial performance criteria upon completion of the year ended December 31, 2014 and the reporting person's satisfaction of the service requirement as of February 27, 2015. Restricted stock units were converted to shares of common stock on a 1.0-for-1.1 basis, as performance targets were achieved above the targeted level.
- Shares withheld to satisfy applicable withholding taxes in connection with conversion of restricted stock units.
- The reporting person disclaims any beneficial ownership of all shares owned by his sons. The filing of this statement shall not be construed as an admission that the reporting person is, for purposes of Section 16 of the Exchange Act of 1934 or for any other purpose, the beneficial owner of the securities owned by his sons.
- Vests in five equal annual installments beginning on February 27, 2016.
- Award of restricted stock performance units pursuant to the Chemical Financial Corporation Stock Incentive Plan of 2012. Restricted stock units under this award are convertible into shares of common stock based on the attainment by the Company of certain financial performance criteria in the year ending December 31, 2017 and the reporting person's satisfaction of the service requirement in February 2018. Restricted stock units under this award are reported assuming shares of common stock will be issuable on a 1-for-1 basis, but restricted stock units may be convertible on a basis ranging from 0.5-for-1 to 1.5-for-1 depending on the actual performance of the Company.
- Award of restricted stock service-based units convertible into shares of common stock on a 1-for-1 basis at the end of a 5-year vesting period. Dividend equivalents will accrue under this award.